Search

Financial results - BALKAN PHARMACEUTICALS SOCIETATE CU RASPUNDERE LIMITATĂ

0.00
Financial Summary - Balkan Pharmaceuticals Societate Cu Raspundere Lim
Unique identification code: 5758562
Registration number: J1994000865332
Nace: 2120
Sales - Ron
5.135
Net Profit - Ron
-532.153
Employees
Open Account
Company Balkan Pharmaceuticals Societate Cu Raspundere Lim with Fiscal Code 5758562 recorded a turnover of 2024 of 5.135, with a net profit of -532.153 and having an average number of employees of - . The company operates in the field of Fabricarea preparatelor farmaceutice having the NACE code 2120.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Balkan Pharmaceuticals Societate Cu Raspundere Lim

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 51.402 76.277 79.674 80.945 80.049 80.008 83.291 13.939 0 5.135
Total Income - EUR 54.906 188.976 80.093 80.998 251.851 81.162 324.228 522.601 40.315 327.534
Total Expenses - EUR 35.399 73.693 46.877 58.510 77.122 64.804 68.482 479.261 211.117 858.559
Gross Profit/Loss - EUR 19.507 115.283 33.215 22.489 174.729 16.358 255.746 43.340 -170.802 -531.025
Net Profit/Loss - EUR 17.860 97.576 27.856 21.679 172.210 15.547 252.504 38.114 -170.997 -532.153
Employees 1 1 2 3 5 3 4 4 4 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Balkan Pharmaceuticals Societate Cu Raspundere Lim

Rating financiar

Financial Rating -
BALKAN PHARMACEUTICALS SOCIETATE...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Balkan Pharmaceuticals Societate...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Balkan Pharmaceuticals Societate...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Balkan Pharmaceuticals Societate...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Balkan Pharmaceuticals Societate Cu Raspundere Lim - CUI 5758562

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 354.012 513.909 484.696 455.748 697.613 700.115 1.094.883 2.526.106 12.050.361 12.610.468
Current Assets 19.430 25.417 20.486 21.093 102.367 40.175 755.651 4.231.764 2.071.442 3.452.890
Inventories 0 0 0 0 0 0 0 0 0 29.528
Receivables 7.565 14.694 10.096 18.757 45.637 25.616 20.003 3.833.806 1.574.737 3.401.204
Cash 11.865 10.723 10.391 2.336 56.730 14.559 735.648 397.958 496.705 22.158
Shareholders Funds 285.212 362.202 288.004 277.053 422.639 261.227 492.736 279.092 2.686.962 2.139.793
Social Capital 267.353 264.626 260.148 255.374 246.744 242.067 236.698 237.433 2.816.426 2.800.686
Debts 88.230 177.124 217.179 199.789 377.342 479.063 1.357.797 2.254.758 7.111.272 9.932.864
Income in Advance 0 0 0 0 0 0 0 4.224.020 4.323.569 3.990.702
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "2120 - 2120"
CAEN Financial Year 2120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 3.452.890 euro in 2024 which includes Inventories of 29.528 euro, Receivables of 3.401.204 euro and cash availability of 22.158 euro.
The company's Equity was valued at 2.139.793 euro, while total Liabilities amounted to 9.932.864 euro. Equity decreased by -532.153 euro, from 2.686.962 euro in 2023, to 2.139.793 in 2024. The Debt Ratio was 61.8% in the year 2024.
Monitors the Company

Risk Reports Prices

Reviews - Balkan Pharmaceuticals Societate Cu Raspundere Lim

Comments - Balkan Pharmaceuticals Societate Cu Raspundere Limitată

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.